Future studies should assess the long-term efficacy of CFTR modulators in CF in larger samples; the efficacy in the child population at early stages of the disease; in outcome measures related to QoL, perceived symptoms, and physical activity; and their possible application in rare CF genotypes or other diseases [73]. The gene discussed is CFTR; the disease is cystic fibrosis.